Sutro Biopharma, Inc. (STRO) — DEF 14A Filings
All DEF 14A filings from Sutro Biopharma, Inc.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
Sutro Biopharma DEF 14A: Executive Equity Awards Detailed
— Apr 25, 2025 Risk: low
Sutro Biopharma, Inc. filed a DEF 14A on April 25, 2025, detailing executive compensation and equity awards for the fiscal years ending December 31, 2022, 2023, -
Sutro Biopharma, Inc. Files DEF 14A with Executive Compensation Details
— Apr 26, 2024 Risk: low
SUTRO BIOPHARMA, INC. (STRO) filed a Proxy Statement (DEF 14A) with the SEC on April 26, 2024. Sutro Biopharma, Inc. (STRO) filed a DEF 14A on April 26, 2024, f
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX